Geron Corporation (Nasdaq: GERN) today announced the enrollment of the first patient in the company's clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1.This is the first thing that Ron Johnson would put an end to.
And Scott Walker would ban it.
Compassionate conservatism lives on (for zygotes).
1 comment:
At least until they are born. After that, all their problems are due to their parent's lack of bootstraps or the will to pull up on them.
Post a Comment